Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir Intensification on Endothelial Function in HIV
NCT00843713Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2009
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Raltegravir with Placebo (2 arms). Primary endpoint: Endothelial Function Measured by Brachial Artery Flow-mediated Dilation at 24 weeks. Started Jan 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00843713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843713.